Management

		Ole Thastrup CEO, prior to co-founding 2cureX, Ole Thastrup was Head of Carlsberg Biosectorwhere he was responsible for Carlsberg’s biomedical research. Before that he was the scientific founder and Chief Scientific Officer of BioImage A/S (now Thermo Fischer BioImage) that was spun-out of Novo Nordisk A/S as a drug discovery company fostering the novel discovery concept of Redistribution™. Ole Thastrup has furthermore experience in managing drug discovery research units in the pharmaceutical and biotechnology industry (Novo Nordisk A/S and ZymoGenetics, Inc.).
		Timm Jessen CBO, who is co-founder of 2cureX, started his commercial career with Hoechst (pre-clinical discovery) where he became Steering Committee member of Hoechst’s collaborations with OSI Pharm., Incyte and Lynx and member of the Biotech Integration Team throughout the merger with Roussell and Marion Merrell Dow. Subsequently Timm Jessen became CSO and COO of EvotecOAI. He was instrumental for Evotec OAI´s strategic move into proprietary discovery programs, in partnership with other biotech companies (e.g. DeveloGen).
		Grith Hagel Head of Project Management, is co-founder of 2cureX. She has a comprehensive experience in developing and running drug screening campaigns. She is the inventor of several patents on advanced cell-based, high throughput screening technologies. Grith Hagel has 10 years experience from the pharma industry (Novo Nordisk) and project management expertise from the biotechnology industry (BioImage and Carlsberg). Grith Hagel was co-founder of BioImage.